tm
Seeing Is Believing
tm
Seeing Is Believing
PHAR is currently covered by 2 analysts with an average price target of $34.74. This is a potential upside of $24.64 (243.96%) from yesterday's end of day stock price of $10.1.
Pharming Group NV's activity chart (see below) currently has 5 price targets and 14 ratings on display. The stock rating distribution of PHAR is 100% BUY.
Highest price target for PHAR is $37, Lowest price target is $30, average price target is $33.5.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 16-Dec-2024. First documented stock forecast 16-Feb-2023.
Currently out of the existing stock ratings of PHAR, 10 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$37
$26.75 (260.98%)
$37
7 months 7 days ago
(16-Dec-2024)
0/12 (0%)
$28.11 (316.20%)
Buy
$30
$19.75 (192.68%)
$40
8 months 25 days ago
(28-Oct-2024)
0/2 (0%)
$21.16 (239.37%)
What is PHAR (Pharming Group NV) average time for price targets to be met?
Which analyst has the current highest performing score on PHAR (Pharming Group NV) with a proven track record?
Which analyst has the current lower performing score on PHAR (Pharming Group NV) with a proven track record?
Which analyst has the most public recommendations on PHAR (Pharming Group NV)?
Which analyst is the currently most bullish on PHAR (Pharming Group NV)?
Which analyst is the currently most reserved on PHAR (Pharming Group NV)?
